"The CDSCO (Central Drugs Standard Control Organisation) has approved
a vital randomised controlled trial on Covid-19 treatment with a
biological called tocilizumab, in the first proposed multi-centre
trial with the drug in India," said Dr AS Soin, national lead
investigator for the trial.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/clinical-trials-using-arthritis-drug-get-nod/articleshow/75684454.cms
No comments:
Post a Comment